Arleide Lee is a Principal Scientist with 13 years of experience in the pre-clinical stage of various oncology indications. They have designed and managed outsourced assays and participated in cross-functional teams to drive data-informed decisions for advancing drug candidates to IND. Previously, Arleide completed a Ph.D. and worked at multiple research institutions, including Epizyme and Berg, LLC. Currently, they focus on the triage, evaluation, and due diligence of assets in rare diseases for in-licensing and external innovation at IPSEN.
This person is not in the org chart
This person is not in any teams
This person is not in any offices